Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04746924
Brief Title: A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

First Submitted : February 5, 2021
First Submitted that Met QC Criteria : February 5, 2021
First Posted : February 10, 2021

Last Update Submitted that Met QC Criteria : November 1, 2021
Last Update Posted : November 3, 2021